A case of chronic obstructive pulmonary disease with pulmonary hypertension and oedema is presented, with reversal of hypoxaemia over 18 months during treatment with long term oxygen therapy. (Thorax 1993;48:576-577) The prognosis of patients with chronic obstructive pulmonary disease (COPD) complicated by hypoxaemia, hypercapnia, pulmonary arterial hypertension, and oedema is grave with one third of such patients dying within three years.12 Only long term oxygen theory (LTOT) improves survival in such patients34 and may halt the progression of pulmonary hypertension.56 trocardiography showed sinus tachycardia 110/min, right axis deviation, P pulmonale, and signs of right ventricular hypertrophy. Sputum culture on one occasion grew Pseudomonas aeruginosa. His arterial blood gas tensions on admission while breathing oxygen, 2 I/min via nasal prongs, were: arterial oxygen tension (Pao,) 5 9 kPa, arterial carbon dioxide tension (Paco2) 11.0 kPa, [H+] 45-6 nmol/l, and HCO,-43 9 mmol/l. Initial treatment with intravenous frusemide (100 mg twice daily) and, additionally, metolazone (5 mg) did not produce a significant diuresis but further impaired renal function (peak blood urea 34 0 mmol/l). In view of this he was commenced on an infusion of dopamine (2 ,ug/kg/min) via a Swan-Ganz catheter. At this time his pulmonary arterial pressure was 28 mm Hg, pulmonary wedge pressure 5 mm Hg, and cardiac output 6 1 1/min. Right ventricular ejection fraction was 0-36 (normal range >0.45).' Treatment with dopamine produced a significant diuresis and his condition improved. He remained stable and oedema free thereafter on frusemide 120 mg/day.
The prognosis of patients with chronic obstructive pulmonary disease (COPD) complicated by hypoxaemia, hypercapnia, pulmonary arterial hypertension, and oedema is grave with one third of such patients dying within three years.12 Only long term oxygen theory (LTOT) improves survival in such patients34 and may halt the progression of pulmonary hypertension.56 trocardiography showed sinus tachycardia 110/min, right axis deviation, P pulmonale, and signs of right ventricular hypertrophy. Sputum culture on one occasion grew Pseudomonas aeruginosa. His arterial blood gas tensions on admission while breathing oxygen, 2 I/min via nasal prongs, were: arterial oxygen tension (Pao,) 5 Case report A 63 year old man, an ex-smoker with longstanding COPD complicated by respiratory failure, was transferred to our unit from another hospital where, despite treatment with diuretics and oxygen, his oedema had not improved. On examination he was dyspnoeic at rest with pitting oedema of both legs and elevated jugular venous pressure. His heart rate was 100 beats/min, regular, and his blood pressure was 140/90 mm Hg; no murmurs were audible. His chest was hyperinflated with bilateral basal crepitations and widespread rhonchi. Abdominal examination revealed a markedly enlarged liver.
The haemoglobin concentration and white blood count were normal. Blood urea was elevated (21 mmol/l) with normal electrolytes. Levels of alkaline phosphatase at 552 units/l and yglutamyl transferase at 395 units/l were both increased on admission and returned to normal before discharge, but albumin was normal. Chest radiographic examination showed cardiomegaly, prominent pulmonary arteries, and lower zone patchy shadowing (fig). Routine 12 lead elec-% . 0 . . . . . S . . . . . . . . . . . . . . . . . . . . . . , .  _ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M . o 6-4-7-4 kPa while breathing air), however, when seen at the clinic 12 months after discharge. His remarkable improvement was observed first after 18 months of treatment with LTOT when his Pao, while breathing air was 8-6 and 9-4 kPa on two occasions and Sao, was more than 90% for more than 50% of a 24 hour period. A possible explanation for the improvement is an improvement in airflow limitation, either spontaneously or in response to treatment; however, no changes in FEV1 or in treatment occurred over the follow up period. Improvement in pulmonary haemodynamics or right ventricular function would be unlikely to occur de novo after 18 months treatment with LTOT since this treatment has been shown to prevent worsening but not to improve pulmonary arterial pressure.35
The lack of change in heart size or right ventricular ejection fraction does not suggest any major change in cardiac function. Furthermore, the width of the right basal pulmonary artery, as a non-invasive measure of pulmonary arterial pressure,9 did not change with treatment. Spontaneous improvement in occult lower respiratory infection or pulmonary thromboembolism 18 months after the acute exacerbation of COPD cannot be excluded, but also seems unlikely. The explanation for the improvement in Pao, therefore remains unclear.
Improvement in Pao, 18 months after discharge is unusual in patients treated with LTOT.10 This patient reinforces the point that reassessment is necessary to determine the continued need for oxygen therapy.
